ClinicalTrials.gg

Humacyte, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 15 studies whose lead sponsor is Humacyte, Inc.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 15, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Humacyte with Daiichi Sankyo and Amgen →

Pipeline: 2 programs

Each counted once: 2 with a study Humacyte, Inc. leads registered in the last two years.

  • Phase 2
  • Phase 4 (approved, new studies)

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Humacyte, Inc.’s own registered studies; Humacyte, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Humacyte, Inc.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Humacyte, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 15 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now320%
  • Under way, not recruiting17%
  • Completed960%
  • Status unknown or other213%Temporarily not available 1 · Approved for marketing 1

Phase

  • Phase 35
  • Phase 24
  • Phase 41
  • Phase 11

Where

  • United States6
  • Poland4
  • Israel2
  • Germany1
  • Portugal1
  • Ukraine1

Over the years

  1. 12
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. 19
  9. 20
  10. 21
  11. 22
  12. 23
  13. 24
  14. 25
  15. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Humacyte, Inc..

  • Humacyte, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    15 studies

Studies

Recruiting first, then most recently updated. Showing 15 of 15.